Clinical trial
Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous…
NCT00285207 · Tigris Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00285207 |
|---|---|
| Title | Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix |
| Official title | A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Trial of the Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix |
| Lead sponsor | Tigris Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia |
| Intervention type | Drug |
| Interventions | placebo, A007 |
| Enrollment | 147 |
| Start date | Jan 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Feb 1, 2006 |
| Last update posted | Oct 11, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: